...
首页> 外文期刊>Medicinal chemistry >Synthesis and in vitro Antioxidant Activity Study of Some Novel Substituted Piperazinyl Flavone Compounds
【24h】

Synthesis and in vitro Antioxidant Activity Study of Some Novel Substituted Piperazinyl Flavone Compounds

机译:一些新型取代哌嗪基黄酮化合物的合成和体外抗氧化活性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background: A new series of 13 piperazinyl flavone derivatives has been synthesizedand examined for their in vitro antiradical and antioxidant activities in response to the pharmacyindustry’s increasing demand for new non-toxic anti-inflammatory and anticancer drugs.Method: Their antioxidant activity was evaluated by the reactive oxygen species (ROS) scavengingassays, 2,2-diphenyl-1-picrylhydrazyl free radical (DPPH?) and 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) radical cation (ABTS+?) scavenging assays, and the ferricreducing antioxidant potency (TAC) method, and was compared to known positive controls, herbalinfusions, and penicillins. Chemiluminescence, spectrophotometry, electron spin resonance (ESR)and 5,5-dimethyl-1-pyrroline-1-oxide (DMPO) as the spin trap were the measurement techniques.Result: It was seen that synthesized compounds have a wide spectrum of antioxidant property.Some of the test compounds proved to be extremely efficient scavengers of H2O2 exhibiting, insome cases, EC50 of about 2 μM. The values of antioxidant status (TAS) were in the range of 49 ±3.9 to 1283 ± 51.3 μM TE/g (TE = Trolox equivalent) and were lower than that of butylated hydroxytoluene(BHT) (1304 ± 43.2 μM TE/g) and green tea (1356 ± 40.0 μM TE/g), but for severalsynthesized compounds, they were higher than chamomille infusion and penicillins. Ferric reducingantioxidant powers (TAC) for the piperazinyl flavone derivatives were in the range 7 ± 0.5 to104 ± 0.6 μM TE/g and were weaker than that of BHT (217 ± 5.3 μM TR/g ).Conclusion: Carboxylic or hydroxamic acid substituted piperazinyl flavones are potentially activeas antioxidants, thus may be suggested as pharmacologically interesting ones.
机译:背景:一系列新的13个哌嗪基黄酮衍生物已被合成,针对体外抗氧化和抗氧化活性检查,以应对Pharacy工业对新的无毒抗炎和抗癌药物的不断增加需求。方法:它们的抗氧化活性由反应性氧(ROS)清除扫描,2,2-二苯基-1-野生酰胺自由基(DPPHα)和2,2'-唑噻唑-6-磺酸(3-乙基苯并噻唑啉-6-磺酸)清除阳离子和碳化抗氧化剂效力(TAC)方法,并与已知阳性对照,草药灌注和青霉素进行比较。化学发光,分光光度法,电子旋转共振(ESR)和5,5-二甲基-1-吡咯啉-1-氧化物(DMPO)作为旋转陷阱是测量技术。结果:可以看出,合成化合物具有广泛的抗氧化剂属性。证明的测试化合物是非常有效的H2O2清除剂,其表现出,Insome病例,EC50约为2μm。抗氧化状态(TAs)的值在49±3.9至1283±51.3μmTe/ g(TE = Trolox当量)的范围内,并且低于丁基化羟基甲苯(BHT)(1304±43.2μmte / g)绿茶(1356±40.0μmte / g),但对于Semeralsized化合物,它们高于Chamomille输液和青霉素。用于哌嗪基黄酮衍生物的铁氧化丙酮毒性功率(TAC)在7±0.5至104±0.6μmTe/ g的范围内,并且比BHT(217±5.3μmtr / g)较弱。结论:羧酸或羟肟酸取代的哌嗪基黄酮是潜在的ActiveAs抗氧化剂,因此可以提出作为药理学上有趣的抗氧化剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号